Quillivant XR 25 MG/5 ML susp 60ML
Ended Awarded
- Contract number
- SPE2DR26FM11Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,519
Award facts
- Contract value 100% obligated
- $7,519.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $7,519.09 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension (60 mL), a pharmaceutical product used in the treatment of attention deficit hyperactivity disorder. The contract, which was competitively awarded with no set-aside designation, was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. This delivery order operates under a firm fixed price arrangement and represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a diverse range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. As a prime contractor holding this substantial contract with DLA, AmerisourceBergen demonstrates established capability to meet federal procurement requirements for pharmaceutical commodities across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26FM11Q?
SPE2DR26FM11Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FM11Q worth?
The government has obligated $7,519 on SPE2DR26FM11Q.
Is contract SPE2DR26FM11Q an order under another contract?
Yes. SPE2DR26FM11Q is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM11Q competed?
The extent of competition for SPE2DR26FM11Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award